2657-25-2
2657-25-2 结构式
基本信息
2-BENZYLIDENE-4'-HYDROXYACETOPHENONE
4'-HYDROXYCHALCONE
BENZYLIDENE-(4-HYDROXYACETOPHENONE)
BENZYLIDENE-4'-HYDROXYACETOPHENONE
HYDROXYCHALCONE, 4'-
4'-Hydroxychalcone,97%
4'-Hydroxychalcone 98%
HYDROXYCHALCONE, 4-(RG)
4'-Hydroxychalcone98%
1-(4-Hydroxyphenyl)-3-phenyl-2-propen-1-one
1-(p-Hydroxyphenyl)-3-phenyl-2-propene-1-one
物理化学性质
知名试剂公司产品信息
4'-Hydroxychalcone, 98%(2657-25-2)
4'-Hydroxychalcone,>95.0%(GC)(2657-25-2)
常见问题列表
| Target | Value |
|
NF-κB
() |
4'-Hydroxychalcone (20-40 μM ; 2 hours) inhibits TNFα-induced (20 ng/mL; 6 hours) NF-kB pathway activation in a dose-dependent manner.
4'-Hydroxychalcone (0.1-25 μM ; 8 hours) inhibits proteasome activity in a dose-dependent manner but has no effect on IKK activity.
4'-Hydroxychalcone inhibits TNFα-dependent degradation of IkBα and subsequently prevents p50/p65 nuclear translocation leading to 4'-Hydroxychalcone-inhibited expression of NF-kB target genes.
4'-Hydroxychalcone affects cancer cell viability but has no significant effect on non-transformed cell viability.
Cell Viability Assay
| Cell Line: | K562 cells, Jurkat cells, U937 cells, PBMCs |
| Concentration: | 5 μM, 10 μM, 20 μM, 24 μM, 28 μM, 32 μM, 40 μM, 60 μM |
| Incubation Time: | 24 hours |
| Result: | Affected cancer cell viability but has no significant effect on non-transformed cell viability. |
Western Blot Analysis
| Cell Line: | Jurkat cells |
| Concentration: | 60 μM (followed by TNFα 20 ng/mL ) |
| Incubation Time: | 2 hours |
| Result: | Inhibited TNFα -dependent degradation of IkBα and prevents p50/p65 nuclear translocation. |
4'-Hydroxychalcone has hepatoprotective activity against Acetaminophen induced hepatotoxicity in mice.
| Animal Model: | Male albino mice(5-30 g) |
| Dosage: | 25 mg/kg, 50 mg/kg, 100 mg/kg |
| Administration: | Oral administration, 12h intervals, 4 doses |
| Result: | Significantly reduced the mortality rate induced by Acetaminophen (1 g/kg). |